Intended for healthcare professionals

News

Companies to pay $39.5m in OxyContin and Risperdal cases

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h7018 (Published 31 December 2015) Cite this as: BMJ 2015;351:h7018